Skip to content
Homepage
Author:
BRECKENRIDGE PHARMACEUTICAL, INC.
Posted Date:
June 4, 2026
Breckenridge announces launch of Tofacitinib Tablets, generic equivalent of Xeljanz® by Pfizer
BRECKENRIDGE PHARMACEUTICAL, INC.
June 4, 2026
Breckenridge announces launch of Milnacipran HCl Tablets, generic equivalent of Savella®
BRECKENRIDGE PHARMACEUTICAL, INC.
March 19, 2026
Breckenridge Pharmaceutical enters strategic partnership with Maiva Pharma Pvt. Ltd.
BRECKENRIDGE PHARMACEUTICAL, INC.
March 11, 2026
Breckenridge launches Pomalidomide Capsules, strengthening its oncology portfolio
BRECKENRIDGE PHARMACEUTICAL, INC.
March 2, 2026
Breckenridge Pharmaceutical announces strategic collaboration with Medichem
BRECKENRIDGE PHARMACEUTICAL, INC.
February 7, 2026
